Nanxin Pharmaceutical intends to acquire Suzhou Xingmeng in cash
Synermore is a biotechnology company focused on the treatment of malignant tumors, dedicated to the research and development of innovative and biosimilar monoclonal antibodies in the fields of oncology, infectious diseases and immune diseases. The core competency is taking products from the research phase through non-clinical and CMC activities supporting IND into clinical development. Nanxin […]
Nanxin Pharmaceutical intends to acquire Suzhou Xingmeng in cash Read More »